SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-024508
Filing Date
2020-05-12
Accepted
2020-05-12 10:57:11
Documents
54
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q caba-10q_20200331.htm 10-Q 1967421
2 EX-31.1 caba-ex311_8.htm EX-31.1 20052
3 EX-31.2 caba-ex312_7.htm EX-31.2 20029
4 EX-32.1 caba-ex321_10.htm EX-32.1 10559
5 EX-32.2 caba-ex322_6.htm EX-32.2 10656
  Complete submission text file 0001564590-20-024508.txt   5762386

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT caba-20200331.xml EX-101.INS 1083215
7 XBRL TAXONOMY EXTENSION SCHEMA caba-20200331.xsd EX-101.SCH 43679
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE caba-20200331_cal.xml EX-101.CAL 28796
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE caba-20200331_def.xml EX-101.DEF 149216
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE caba-20200331_lab.xml EX-101.LAB 331656
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caba-20200331_pre.xml EX-101.PRE 250073
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39103 | Film No.: 20867442
SIC: 2836 Biological Products, (No Diagnostic Substances)